Coppell Advisory Solutions LLC lifted its stake in shares of Centene Co. (NYSE:CNC – Free Report) by 302.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,918 shares of the company’s stock after acquiring an additional 1,441 shares during the period. Coppell Advisory Solutions LLC’s holdings in Centene were worth $116,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the stock. Stratos Wealth Partners LTD. boosted its position in shares of Centene by 4.1% during the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock worth $248,000 after purchasing an additional 163 shares in the last quarter. Capital Advisors Ltd. LLC increased its holdings in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares in the last quarter. Private Trust Co. NA raised its position in shares of Centene by 23.7% during the fourth quarter. Private Trust Co. NA now owns 956 shares of the company’s stock worth $58,000 after purchasing an additional 183 shares during the period. Howard Capital Management Inc. lifted its holdings in shares of Centene by 5.4% in the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company’s stock worth $218,000 after purchasing an additional 184 shares in the last quarter. Finally, Intellectus Partners LLC increased its stake in Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company’s stock valued at $438,000 after purchasing an additional 200 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Centene Stock Performance
NYSE CNC opened at $57.74 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The company has a market capitalization of $28.64 billion, a PE ratio of 9.25, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53. Centene Co. has a 52-week low of $55.03 and a 52-week high of $80.59. The company has a 50-day simple moving average of $60.10 and a 200 day simple moving average of $60.97.
Analyst Ratings Changes
A number of research analysts have recently issued reports on CNC shares. Guggenheim began coverage on shares of Centene in a report on Wednesday, April 9th. They set a “neutral” rating for the company. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a report on Friday, April 11th. Argus lowered Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Wells Fargo & Company decreased their price target on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of Centene from an “underperform” rating to a “hold” rating and lifted their price objective for the stock from $53.00 to $64.00 in a report on Tuesday, April 8th. Seven analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $80.69.
Read Our Latest Analysis on Centene
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- Most active stocks: Dollar volume vs share volume
- Short Sellers Gave Up on These 3 Names Recently
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Boring Stocks Outperforming the Market This Year
- How to Profit From Growth Investing
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.